![James G. Kaiser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James G. Kaiser
Presidente en Kaiser Services LLC .
Origen de la red de primer grado James G. Kaiser.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Quanterra, Inc.
![]() Quanterra, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Dow Silicones Corp., Quanterra, Inc. provides lab analysis. Quanterra was acquired by Dow Silicones Corp. from IT Group, Inc. on June 26, 1998 for $5.75 million.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a James G. Kaiser a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
AgraQuest, Inc.
![]() AgraQuest, Inc. Chemicals: AgriculturalProcess Industries AgraQuest, Inc. develops pesticides and provides best management services. The company was founded in 1995 and is headquartered in Research Triangle Park, NC. | Chemicals: Agricultural | Chief Executive Officer | |
University of California, Davis | College/University | Doctorate Degree | |
Stanford University | College/University | Undergraduate Degree | |
Zoogen, Inc.
![]() Zoogen, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Applied Biosystems, Inc., Zoogen, Inc. provides genetic analysis services to owners of domestic and exotic animals. The company is based in Davis, CA. Zoogen was acquired by Applera Corp. on April 05, 1996. | Miscellaneous Commercial Services | President | |
Lipomics Technologies, Inc.
![]() Lipomics Technologies, Inc. BiotechnologyHealth Technology Lipomics is uniquely positioned as a leader in personalized medicine for metabolic disorders. Developing diagnostics for metabolic diseases. Its research and development efforts apply proprietary techniques in lipid profiling and data interpretation to identify clinically relevant biomarkers and validate their potential for diagnostic tests. Working with strategic partners, Lipomics Technologies is advancing its goal to develop clinical diagnostic tools with an emphasis on high-density lipoprotein metabolism, diabetes, weight loss and inflammation. Its service unit provides biomarker discovery and biological consultation services for advancing drug development with their pharmaceutical partners. The company generates high-quality quantitative profiles of lipid metabolites that are central to metabolic diseases. These metabolites include eicosanoids, acylcarnitines, sterols, bile acids and structural and energetic lipids. In addition to quantitative metabolite profiling, Lipomics provides bioinformatic analysis and biological interpretation services. | Biotechnology | Director/Board Member | |
Sutter Davis Hospital Foundation | Miscellaneous Commercial Services | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 8 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 3 |
Process Industries | 2 |
Operativa
President | 3 |
Chief Operating Officer | 2 |
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Doctorate Degree | 1 |
Las relaciones más conectadas
Insiders | |
---|---|
Michael J. Miille | 8 |
- Bolsa de valores
- Insiders
- James G. Kaiser
- Conexiones Empresas